🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chelsea McLean

Janssen (Netherlands)

ORCID: 0000-0002-3548-3482

Also affiliated with Johnson & Johnson (Netherlands)

MedicineBiochemistry, Genetics and Molecular BiologySocial SciencesHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study.

52 citations

Muhammad Assad Aslam, Mir Farshid Alemdehy, Teun van den Brand, Chelsea McLean, Hanneke Vlaming +12 more